Endocr Connect 10(7):R200R212
Can I tell how potent my compounded tirzepatide is at home
The research, published in JAMA Psychiatry, provides reassurance that use of GLP1-RAs, such as semaglutide, are not associated with any increased risk of psychiatric adverse events or worsening of depressive symptoms
District Court in Trenton, claim that Novo Nordisk failed to adequately warn doctors and patients about the risk of developing Non-Arteritic Anterior Ischemic Optic Neuropathy, also called NAION, a serious and irreversible condition that leads to sudden blindness. SI live June 18, 2025- Already facing thousands of Ozempic lawsuits and Wegovy lawsuits over gastrointestinal problems that have been brought in the federal court system, Novo Nordisk now also faces a growing number of claims involving vision loss, which some plaintiffs are requesting be consolidated into a mass tort in New Jersey state court. About lawsuits June 18, 2025- June 6, 2025- European Medicines Agency report May 20, 2025- More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision
-1775582746855.png&w=3840&q=75)
